Task: Answer the multiple choice question.
Question: Which compound exhibits a -24.577% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) C/C(=N\O)C(=O)NCC1CCNCC1
b) Cc1cnc(C(=O)NC2CC(C)(C)Cc3c2cnn3-c2ccccc2)cn1
c) CC1CCN(C(=O)C2CCN(S(=O)(=O)c3cccc4nsnc34)CC2)CC1
Answer: c. CC1CCN(C(=O)C2CCN(S(=O)(=O)c3cccc4nsnc34)CC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(C(=O)C2CCN(S(=O)(=O)c3cccc4nsnc34)CC2)CC1
CC1CCN(C(=O)C2CCN(S(=O)(=O)c3cccc4nsnc34)CC2)CC1
[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperidin-4-yl]-(4-methylpiperidin-1-yl)methanone